Drug Erlotinib
- All
- News
-
Roche, Glenmark Settle Patent Litigation Over Cancer Drug
Swiss pharma major F Hoffmann-La Roche and India's Glenmark Pharmaceuticals have settled out of court a patent litigation over the former's lung cancer drug erlotinib hydrochloride sold under the brand name 'Tarceva'.
-
A Cancer 'You Live With Until the Next Discovery'
It was just a tiny bump behind Corey Wood's right eye, but her doctor was concerned. The college senior and marathon runner felt fine, but a full-body scan revealed that she had Stage 4 lung cancer.
-
Cipla Weighs Legal Options After Patent Ruling by Court
Drug major Cipla is exploring all legal options in the wake of Delhi High Court's ruling that it has infringed Swiss drug major Hoffman-La Roche's patent on lung cancer drug erlotinib hydrochloride.
-
Roche, Glenmark Settle Patent Litigation Over Cancer Drug
Swiss pharma major F Hoffmann-La Roche and India's Glenmark Pharmaceuticals have settled out of court a patent litigation over the former's lung cancer drug erlotinib hydrochloride sold under the brand name 'Tarceva'.
-
A Cancer 'You Live With Until the Next Discovery'
It was just a tiny bump behind Corey Wood's right eye, but her doctor was concerned. The college senior and marathon runner felt fine, but a full-body scan revealed that she had Stage 4 lung cancer.
-
Cipla Weighs Legal Options After Patent Ruling by Court
Drug major Cipla is exploring all legal options in the wake of Delhi High Court's ruling that it has infringed Swiss drug major Hoffman-La Roche's patent on lung cancer drug erlotinib hydrochloride.
